2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow JUNYAN ZHANG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial Ranibizumab, Triamcinolone Acetonide - Proliferative Diabetic Retinopathy | Phase 3 | Unknown | JUNYAN ZHANG | 200 | 2015-06-01 | 2018-09-24 |
| 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China Ranibizumab, Triamcinolone Acetonide - Proliferative Diabetic Retinopathy | Phase 2 / Phase 3 | Unknown | JUNYAN ZHANG | 120 | 2015-02-01 | 2016-08-25 |
Ranibizumab (2) · Triamcinolone Acetonide (2)
China (2)
PMID 15564755, PMID 17804919, PMID 20332654, PMID 20572497, PMID 21860693, PMID 22737347, PMID 22737351, PMID 22848140, PMID 24339677, PMID 24379924